Healthy Volunteer Undergoing Painful Stimuli With and Without Hypnosis and Virtual Reality (SMARTHY)

September 29, 2022 updated by: Oncomfort

Healthy Volunteer Undergoing Painful Stimuli With and Without Virtual Reality Hypnosis (VRH)

The main purposes of this study are as follows:

Compare the effect of painful stimuli with and without Hypnosis and Virtual Reality (HVR) on healthy volunteers.

  • Use of sensors and captors to monitor physiological and neurophysiological changes by painful stimulus
  • Monitor level of pain and anxiety with and without HVR
  • Monitor level of unpleasantness of the pain with and without HVR
  • Monitor level of Anxiety, Absorption, Dissociation, Satisfaction and Comfort with and without HVR

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The control of pain and anxiety in a hospital environment is usually managed by pharmacological means that involve a series of risks and side effects.

For many years, non-drug solutions have been of interest to the public and the care staff. The benefits of hypnosis and of virtual reality are highlighted in many studies and today allow a different approach to medicine. It is important to invest in tools that are less expensive and also effective for the well-being of the patient and the care staff. The use of a blended solution using both clinical hypnosis and virtual reality has been only scarcely documented.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Liege, Belgium, 4000
        • Université de Liège- CHU

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

- 18 years old to 70 years of age

Exclusion Criteria:

  • Deaf subject
  • Blind
  • Non-proficiency in French (research language)
  • Psychiatric disorder
  • Patient under 18 years old
  • Phobia of deep water
  • Head or face wounds
  • Claustrophobia
  • Neurological disease
  • Allergy to cutaneous electrodes
  • Chronic pain and/or chronic analgesics consumption
  • Medication affecting the autonomic nervous system
  • Dizziness

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Painful stimuli with Hypnosis and Virtual Reality
After 5 minutes of rest, we start with painful stimuli during 10 minutes. This session takes place under hypnosis
Subjects will undergo painful stimuli without HVR followed by a session with HVR. Subjects are their own control
No Intervention: Painful stimuli without Hypnosis and Virtual reality
After 5 minutes of rest, we start with painful stimuli during 10 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compare physiological and neurophysiological changes to painful stimulation with and without Hypnosis and Virtual Reality (HVR)
Time Frame: During the procedure
To understand the effect of VRH on the Physiological and neurophysiological parameters recorded by sensors and captors
During the procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain and anxiety
Time Frame: Immediately before and after the procedure

To understand the effect of VRH on the level of pain and anxiety. Pain and anxiety Pain assessed by visual analogue scale (VAS).

Participants will record their pain intensity rating on a Visual analogue scale where 0 = No pain and 10 = worst imaginable pain. Subject will record also their level of anxiety on the same VAS

Immediately before and after the procedure
Unpleasantness of the pain
Time Frame: Immediately after the procedure
To understand the effect of VRH on the level of the unpleasantness of the pain assessed by visual analogue scale. Participants similarly record their pain unpleasantness parting on a VAS where 0= not at all unpleasant and 10= most unpleasantness imaginable.
Immediately after the procedure
Absorption, Dissociation, Satisfaction and comfort, presence and cybersickness
Time Frame: Immediately after the procedure
To understand the effect of VRH on the level of Absorption, Presence, Dissociation, Satisfaction and comfort assessed by visual analogue scale. Participant record their level of absorption, dissociation, satisfaction and comfort on a VAS where 0 = no absorption, no dissociation, no satisfaction and no comfort at all. 10 is the opposite
Immediately after the procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 2, 2019

Primary Completion (Actual)

January 21, 2020

Study Completion (Actual)

August 30, 2022

Study Registration Dates

First Submitted

September 23, 2019

First Submitted That Met QC Criteria

September 25, 2019

First Posted (Actual)

September 27, 2019

Study Record Updates

Last Update Posted (Actual)

September 30, 2022

Last Update Submitted That Met QC Criteria

September 29, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • PILOT 1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Digital Sedation

Clinical Trials on Virtual Reality

3
Subscribe